Quest Diagnostics, Inc. (DGX)
193.82
+0.07
(+0.04%)
USD |
NYSE |
May 21, 16:00
193.68
-0.14
(-0.07%)
Pre-Market: 19:59
Quest Diagnostics Cash from Investing (Quarterly) : -152.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Guardant Health, Inc. | 699.42M |
| Labcorp Holdings, Inc. | -322.10M |
| DaVita, Inc. | -153.23M |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | 10.94M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 278.00M |
| Cash from Financing (Quarterly) | -152.00M |
| Free Cash Flow | 1.326B |
| Free Cash Flow Per Share (Quarterly) | 1.464 |
| Free Cash Flow to Equity (Quarterly) | 140.00M |
| Free Cash Flow to Firm (Quarterly) | 204.48M |
| Free Cash Flow Yield | 6.08% |